Impact of standardized fortified donor human milk on growth parameters and biomarkers in preterm very low birth weight infants: a single-center propensity score-matched analysis - Scorecard - MDSpire

Effects of Standardized Fortified Donor Human Milk on Growth Metrics and Biomarkers in Preterm Infants with Very Low Birth Weight: A Propensity Score-Matched Study from a Single Center

  • By

  • Hui Zan

  • Xiaocui Zhang

  • Shan Ma

  • Hong Zhang

  • July 17, 2026

Share

Clinical Scorecard: Effects of Standardized Fortified Donor Human Milk on Growth Metrics and Biomarkers in Preterm Infants with Very Low Birth Weight: A Propensity Score-Matched Study from a Single Center

At a Glance

CategoryDetail
ConditionPreterm Very Low Birth Weight Infants
Key MechanismsStandardized Fortified Donor Human Milk (SF-DHM) improves growth parameters and nutritional biomarkers.
Target PopulationPreterm infants with birth weight <1,500 g hospitalized in NICU.
Care SettingNeonatal Intensive Care Unit (NICU)

Key Highlights

  • SF-DHM leads to superior weight gain and growth velocities compared to conventional feeding.
  • Lower incidence of extrauterine growth restriction at discharge in the SF-DHM group.
  • Improved nutritional biomarkers and reduced inflammatory markers observed with SF-DHM.
  • Lower rates of feeding intolerance and complications in the SF-DHM group.

Guideline-Based Recommendations

Diagnosis

  • Identify preterm infants with very low birth weight for nutritional intervention.

Management

  • Implement SF-DHM as a primary nutritional source for VLBW infants with insufficient maternal milk.

Monitoring & Follow-up

  • Regularly assess growth parameters and nutritional biomarkers during hospitalization.

Risks

  • Monitor for potential feeding intolerance and complications associated with nutritional interventions.

Patient & Prescribing Data

Preterm infants with gestational age <32 weeks and birth weight <1,500 g.

SF-DHM is a safe and effective enteral nutrition strategy for VLBW infants.

Clinical Best Practices

  • Prioritize the use of SF-DHM in the nutritional management of preterm infants.
  • Ensure systematic treatment and enteral feeding initiation after clinical stabilization.

Related Resources & Content

    Original Source(s)

    Related Content